Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Bolt Biotherapeutics | 46 | 2023q3 | |||||||||
AnaptysBio | 576 | 2023q3 | |||||||||
Luminar Technologies | 1,258 | 2023q3 | |||||||||
Editas Medicine | 679 | 2023q3 | |||||||||
Recursion Pharmaceuticals | 1,614 | 2023 | |||||||||
Sorrento Therapeutics | 11 | 2023q2 | |||||||||
Bionano Genomics | 11 | 2023q3 | |||||||||
Arrowhead Pharmaceuticals | 2,917 | 2023q3 | |||||||||
2seventy bio | 229 | 2023q3 | |||||||||
Seer | 110 | 2023q3 | |||||||||
Compugen | 164 | 2021 | |||||||||
CureVac BV | 742 | 2024q1 | |||||||||
AbCellera Biologics | 783 | 2023q3 | |||||||||
Liquidia | 707 | 2023q3 | |||||||||
bluebird bio | 150 | 2023q3 | |||||||||
22nd Century Group | 4 | 2023q3 | |||||||||
Spruce Biosciences | 30 | 2023q3 | |||||||||
Aurinia Pharmaceuticals | 958 | 2021 | |||||||||
Canopy Growth | 702 | 2024q3 | |||||||||
CARA Therapeutics | 47 | 2021 |